Selank

Selank is a heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a synthetic analog of immunomodulatory peptide tuftsin with an added Glyproline sequence, providing enhanced stability. Research indicates Selank may influence the expression of brain-derived neurotrophic factor (BDNF) and affect the balance of T helper cell cytokines. Studies suggest potential applications in cognitive research and stress-related investigations. This lyophilized peptide is supplied at 10mg per vial for research purposes only.